CD274 and neoplasm: PD-L1 can be overexpressed on tumor cells and tumor-infiltrating immune cells, which binds PD-1 expressed on activated T cells to suppress the activation of T cells and induce T-cell exhaustion, resulting in the immune evasion of cancer cells.